Header image

Session 11: AI & The Future of Benign Haematology

Tracks
Plenary Hall
Sunday, March 29, 2026
11:45 AM - 12:15 PM

Speaker

Agenda Item Image
Prof. Drew Provan
Emeritus Reader in Autoimmune Haematology
Barts and The London School of Medicine and Dentistry

AI in My Clinic: What’s Real, What’s Hype?

11:45 AM - 12:00 PM

Biography

Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.
Agenda Item Image
Dr. Namrata Singh
Founder & CEO
Turacoz Group

Building Trust in AI Tools: What Clinicians Should Ask Before Using Them

12:00 PM - 12:15 PM

Biography


Session Chair

Agenda Item Image
Ahmad Tarawah
President, Madinah Hereditary Blood Disorders Society
President, Middle East and North Africa Hematology League





loading